TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity. - Wikidata - wikimedia - TriplyDB

TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity.

TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity.

http://www.wikidata.org/entity/Q37414989

about

Pharmacology and physiology of gastrointestinal enteroendocrine cells Novel Small Molecule Agonist of TGR5 Possesses Anti-Diabetic Effects but Causes Gallbladder Filling in Mice TGR5, Not Only a Metabolic Regulator.Canavanine induces insulin release via activation of imidazoline I3 receptors.Bile acid metabolism in liver pathobiology.Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.Cryptotanshinone Inhibits STAT3 Signaling to Alleviate Cardiac Fibrosis in Type 1-like Diabetic Rats.

P2860

Q26799380-FB2A3BB2-F5CB-4045-BE19-DFDE3D48B0A7 Q28547520-51243248-D9EC-4516-BD60-28B9031EC075 Q37531608-DF4A754D-8CA3-43A5-A8F7-10D6B73C6571 Q41720415-1D07A8DB-C7FB-4105-8488-CEC058707097 Q47645986-5B6645B9-DD07-44D7-991E-113B1D115779 Q47779219-E8C2CB9F-CE45-47E5-9624-1A572DB38763 Q48263982-C5D1E521-7B8D-49A2-8F1A-3582719318A1

P2860

TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity.

http://www.wikidata.org/entity/Q37414989

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

TRC210258, a novel TGR5 agonis ...... in animal models of diabesity.

@en

TRC210258, a novel TGR5 agonis ...... in animal models of diabesity.

@nl

type

label

TRC210258, a novel TGR5 agonis ...... in animal models of diabesity.

@en

TRC210258, a novel TGR5 agonis ...... in animal models of diabesity.

@nl

prefLabel

TRC210258, a novel TGR5 agonis ...... in animal models of diabesity.

@en

TRC210258, a novel TGR5 agonis ...... in animal models of diabesity.

@nl

P1433

Q37414989-9C2BB6AA-1458-4906-B469-E121B0C942EB

P1476

Q37414989-B97CC6F0-3944-46E4-8AB8-1E457EB1CB0D

P2093

Q37414989-078954BD-D959-42CC-9B38-6B2C5D0EFDF6

Q37414989-1F8F8AD2-3299-417C-9B86-7AD4A7387475

Q37414989-2B256879-5DAB-4C5E-B188-6075E5823D6A

Q37414989-3FF4EEC1-59E6-40ED-90D3-90C1F2C6C56A

Q37414989-76DDD2E7-1F44-43A0-AB41-EF64DF5DFB98

Q37414989-8D5996EF-34CE-4786-A452-4A9D52E6E69B

Q37414989-9EB4155F-85BB-4F91-9646-751D81A79438

Q37414989-A718174B-BC1C-40E7-9CAE-EE9FD44E30E0

Q37414989-FD2190E4-92F6-480A-A2AB-C6AC04FB7F1C

P2860

Q37414989-072908A3-0705-4F64-B255-7F1B796C8468

Q37414989-1763DEBE-AA24-4EAD-92AB-A2F36DA0B167

Q37414989-394C93B6-BC08-4B01-B8FA-EEE178E4E17D

Q37414989-4FBA4966-2415-40AF-A176-570F1345C891

Q37414989-569F4E6A-890B-4BAC-BE90-E47F5A851CFF

Q37414989-5B78FFC1-BFCF-4014-B529-727E580A64A7

Q37414989-6141248B-6A77-4490-BA25-10ECBE35C0D8

Q37414989-6A56EF6F-862E-4A83-AC2B-CCABD3738E4B

Q37414989-7942B052-135A-434B-89C9-A013CE9212BF

Q37414989-7B2C8324-810A-479E-9B25-701CD3E45210

P304

Q37414989-A3E97FDE-6966-446D-98E2-1E40FC8F8CD9

P31

Q37414989-8700B32B-D6D7-4EB9-A779-25D61275E262

P356

Q37414989-CCD4C5F1-3002-41B8-9291-F999A3BEEC1D

P478

Q37414989-01C9F163-E42E-4962-8DAE-F3511C48F214

P577

Q37414989-2C3E7FAA-2548-4386-9EFF-41D2077CBE33

P5875

Q37414989-591E18BE-E912-4691-B555-079EAA4237D6

P698

Q37414989-10C65BE5-7421-486D-9069-9E24EE2FBE9E

P932

Q37414989-EA2C6265-DFD9-4E99-AA3B-80827636404A

P356

P1433

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

P1476

TRC210258, a novel TGR5 agonis ...... in animal models of diabesity.

@en

P2093

Anita R Chaudhary

http://www.w3.org/2001/XMLSchema#string

Anoop Mathur

http://www.w3.org/2001/XMLSchema#string

Chaitanya Dutt

http://www.w3.org/2001/XMLSchema#string

Davinder Tuli

http://www.w3.org/2001/XMLSchema#string

Ramesh C Gupta

http://www.w3.org/2001/XMLSchema#string

Sameer A Ghalsasi

http://www.w3.org/2001/XMLSchema#string

Shailesh Deshpande

http://www.w3.org/2001/XMLSchema#string

Shitalkumar P Zambad

http://www.w3.org/2001/XMLSchema#string

Vijay Chauthaiwale

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of membrane-type receptor for bile acids (M-BAR)

A G protein-coupled receptor responsive to bile acids

Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008

Epidemiology of type 2 diabetes and cardiovascular disease: translation from population to prevention: the Kelly West award lecture 2009.

TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading.

Remnant cholesterol as a causal risk factor for ischemic heart disease.

Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.

Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians

The TGR5 gene is expressed in human subcutaneous adipose tissue and is associated with obesity, weight loss and resting metabolic rate.

P304

1-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DMSO.S50209

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259499999

http://www.w3.org/2001/XMLSchema#string

P698

24379686

http://www.w3.org/2001/XMLSchema#string

P932

3873233

http://www.w3.org/2001/XMLSchema#string